Warm Springs Advisors Inc. Acquires Shares of 26,535 Astera Labs, Inc. $ALAB

Warm Springs Advisors Inc. acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 26,535 shares of the company’s stock, valued at approximately $2,908,000. Astera Labs accounts for about 2.5% of Warm Springs Advisors Inc.’s investment portfolio, making the stock its 13th largest holding.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Reflection Asset Management bought a new position in shares of Astera Labs during the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC lifted its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Hilltop National Bank boosted its stake in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the period. Aventura Private Wealth LLC bought a new position in Astera Labs during the fourth quarter valued at $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in Astera Labs during the fourth quarter valued at $33,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other news, Director Manuel Alba sold 8,491 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the completion of the sale, the director owned 286,863 shares of the company’s stock, valued at approximately $131,492,261.94. The trade was a 2.87% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the sale, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,040,691 shares of company stock worth $507,675,380 over the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of NASDAQ:ALAB traded down $4.48 on Friday, hitting $412.97. 2,158,702 shares of the company’s stock were exchanged, compared to its average volume of 5,804,834. The stock has a market capitalization of $70.79 billion, a price-to-earnings ratio of 279.03, a price-to-earnings-growth ratio of 4.79 and a beta of 3.66. Astera Labs, Inc. has a 12 month low of $88.18 and a 12 month high of $499.48. The business’s 50 day simple moving average is $335.76 and its two-hundred day simple moving average is $214.65.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the topic of several recent analyst reports. Stifel Nicolaus increased their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Evercore reiterated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Royal Bank Of Canada increased their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Susquehanna raised their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Finally, JPMorgan Chase & Co. boosted their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $265.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.